NDC 78714-001
Fludeoxyglucose F-18 300 mCi per 1 mL injection
On the label: Barbara Ann Karmanos Cancer Hospital.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Barbara Ann Karmanos Cancer Hospital | Detroit, MI, United States | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilySep 19, 2025 · 3 inspections |
Product details
- Generic drug
- Fludeoxyglucose F-18: every company that makes it
- Form
- injection, intravenous
- Strength
- 300 mCi per 1 mL
- Approval
- ANDA ANDA204385
- On the market since
- Jan 31, 2020
- Package NDCs
78714-001-30- Official label
- DailyMed (National Library of Medicine), updated Nov 10, 2022
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?